Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome
APT
1 other identifier
observational
134
1 country
1
Brief Summary
The Acute Respiratory Distress Syndrome (ARDS) is one of common clinical critically diseases. In the United States, the incidence of ARDS reaches 31%, which is one of the main causes of death in patients. There is no unified treatment process for ARDS currently and the treatment measures are not yet standardized, so the standardization of ARDS treatment processes is needed to reduce mortality in patients. Following the evidence-based medicine principles and six-step treatment standards of ARDS, this study uses the method of multi-center randomized controlled clinical trials to evaluate the standardized treatment process of ARDS, which provides the basis for the standardized treatment of ARDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 10, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJune 24, 2015
June 1, 2015
1.1 years
June 10, 2014
June 23, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of medical staff who comply the protocol treatment
2 years
Study Arms (2)
standard treatments of ARDS
protocol treatment of ARDS
Eligibility Criteria
ARDS patients
You may qualify if:
- aged ≥ 18 years
- admitted to the ICU
- according to the diagnostic criteria of ARDS Berlin definition,admit patients with severe ARDS
You may not qualify if:
- age \<18 years old
- be expected to die within 24 hours
- end-stage malignancies
- be participating in other studies, which may affect the results of this study
- DNI (do not intubation) and DNR (do not recovery) patients
- family members do not agree to sign an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongda Hospital
Nanjing, Jiangsu, 210009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Zhongda Hospital
Study Record Dates
First Submitted
June 10, 2014
First Posted
July 1, 2014
Study Start
May 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
June 24, 2015
Record last verified: 2015-06